Vol. 3 — May-June 2010

• Regular physical activity and exercise therapy in end-stage renal disease: how should we move forward?
  

  Clara J. Bohm¹, Julie Ho², Todd A. Duhamel³

  (1) Section of Nephrology, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba and Manitoba Renal Program, Winnipeg Regional Health Authority, Winnipeg, Manitoba - Canada
  (2) Section of Nephrology, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Manitoba Renal Program, Winnipeg Regional Health Authority, Winnipeg, Manitoba and Section of Biomedical Proteomics, University of Manitoba, Winnipeg, Manitoba - Canada
  (3) Faculty of Kinesiology and Recreation Management, University of Manitoba, Winnipeg, Manitoba and Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre, Winnipeg, Manitoba - Canada

• Glycosaminoglycan treatment in glomerulonephritis? An interesting option to investigate
  

  Giovanni Gambaro¹, Norella C.T. Kong²

  (1) Division of Nephrology and Dialysis, Columbus-Gemelli University Hospital, Renal Program, Catholic University, Rome - Italy
  (2) Faculty of Medicine, University Kebangsaan Malaysia, Kuala Lumpur - Malaysia

• Chronic kidney disease and cancer: a troubling connection
  

  Benedicte Stengel¹

  (1) Inserm, CESP Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of Diabetes, Obesity and Chronic Kidney Disease over the lifecourse, Université Paris Sud 11, UMRS 1018, Villejuif - France

• Transplant tolerance: progress and challenges
  

  Federica Casiraghi¹, Sistiana Aiello¹, Giuseppe Remuzzi¹

  (1) Mario Negri Institute for Pharmacological Research, Transplant Research Center, “Chiara Cucchi de Alessandri e Gilberto Crespi”, Ranica, Bergamo - Italy

• Microscopic or occult hematuria, when reflex testing is not good laboratory practice
  

  Paul Froom¹, Mira Barak¹

  (1) Central Laboratories Haifa and Western Galilee, Clalit Health Services, Nesher - Israel

• A quality of life comparison in cyclosporine- and tacrolimus-treated renal transplant recipients across Canada
  

  G.V. Ramesh Prasad¹, Michelle M. Nash², Tammy Keough-Ryan³, R. Jean Shapiro⁴

  (1) Division of Nephrology, St. Michael’s Hospital, Toronto, Ontario - Canada
  (2) Renal Transplant Program, St. Michael’s Hospital, Toronto, Ontario - Canada
  (3) Division of Nephrology, Dalhousie University, Halifax, Nova Scotia - Canada
  (4) Department of Medicine, University of British Columbia, Vancouver - Canada

• Serum tryptase levels and markers of renal dysfunction in a population with chronic kidney disease
  

  Ana Esther Sirvent¹, César González¹, Ricardo Enríquez¹, Javier Fernández², Isabel Millán¹, Xavier Barber³, Francisco Amorós¹

  (1) Department of Nephrology, University General Hospital, Elche - Spain
  (2) Allergy Department, University General Hospital, Elche - Spain
  (3) Operations Research Center, Miguel Hernández University, Elche - Spain

• Role of renal sympathetic nervous system in the control of renal potassium handling
  

  Ibrahim M. Salman¹, Munavvar A. Sattar¹, Nor A. Abdullah², Omar Z. Ameer¹, Fathihah Basri¹, NurJannah M. Hussain¹, Mun F. Yam¹, Kolla R.L. Anand Swarup¹, Hassaan A. Rathore¹, Raisa N Kazi¹, Md. Abdul Hye Khan³, Edward J. Johns⁴

  (1) Department of Cardiovascular and Renal Physiology and Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden, Penang - Malaysia
  (2) Department of Pharmacology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur - Malaysia
  (3) Department of Physiology, Tulane Hypertension and Renal Center of Excellence, Tulane University Health Sciences Center, New Orleans, Louisiana - USA
  (4) Department of Physiology, Aras Windle, University College Cork, Cork - Ireland

• Pedometers as a means to increase spontaneous physical activity in chronic hemodialysis patients
  

  Michal Nowicki¹, Katarzyna Murlikiewicz¹, Marta Jagodzinska¹

  (1) Department of Nephrology, Hypertension and Kidney Transplantation, Medical University of Lódz, Lódz - Poland

• Estimate of renal function in oldest old inpatients by MDRD study equation, Mayo Clinic equation and creatinine clearanc
  

  Vincenzo Carnevale^1,2, Luca Pastore¹, Marcello Camaioni¹, Monica Mellozzi¹, Massimo Sabatini¹, Elisabetta Arietti¹, Saverio Fusilli³, Alfredo Scillitani⁴, Mario Pontecorvi¹

  (1) Department of Internal Medicine, “San Giuseppe” Hospital, Albano Laziale, Rome - Italy
  (2) and Department of Internal Medicine, “Casa Sollievo della Sofferenza” Hospital, I.R.C.C.S., San Giovanni Rotondo, Foggia - Italy
  (3) Department of Health Services, “Casa Sollievo della Sofferenza” Hospital, I.R.C.C.S., San Giovanni Rotondo, Foggia - Italy
  (4) Department of Endocrinology, “Casa Sollievo della Sofferenza” Hospital, I.R.C.C.S., San Giovanni Rotondo, Foggia - Italy

• Myocardial scintigraphy and clinical stratification as predictors of events in renal transplant candidates
  

  Rodolfo L. Arantes¹, Luis Henrique W. Gowdak¹, Flavio J. de Paula², Luis Estevan Ianhez², Jose Antonio F. Ramires¹, Eduardo M. Krieger¹, Jose Jayme G. De Lima¹

  (1) Heart Institute (InCor), Hospital das Clínicas, University of São Paulo Medical School, São Paulo - Brazil
  (2) Renal Transplant Unit, Urology Division, Hospital das Clínicas, University of São Paulo Medical School, ?São Paulo - Brazil

• Do statins delay the incidence of ESRD in diabetic patients with moderate CKD?
  

  James Conley¹, Andrew Olafsson¹, Arjang Djamali¹

  (1) Nephrology Section, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin - USA

• Genomic damage in endothelial progenitor cells from uremic patients in hemodialysis
  

  Fulvio Floccari¹, Michele Buemi², Chiara Costa³, Giuseppe Coppolino⁴, Susanna Campo², Davide Bolignano², Alessio Sturiale², Antonio Lacquaniti², Antoine Buemi², Saverio Loddo⁵, Diana Teti⁵

  (1) Nephrology and Dialysis Unit, San Giovanni Evangelista Hospital, Tivoli - Italy
  (2) Chair of Nephrology, Department of Internal Medicine, University of Messina, Messina - Italy
  (3) Department of Social Medicine and Community Health, Occupational Health, University of Messina, Messina - Italy
  (4) Chair of Nephrology, Department of Internal Medicine, University of Messina, Messina and Nephrology and Dialysis Unit, Pugliese-Ciaccio Hospital, Catanzaro - Italy
  (5) Department of Experimental Pathology and Microbiology, University of Messina, Messina - Italy

• Differences in ischemia-modified albumin levels between end stage renal disease patients and the normal population
  

  Suleyman Turedi¹, Orhan Cinar², Izzet Yavuz³, Ahmet Mentese³, Abdulkadir Gunduz¹, Suleyman Caner Karahan³, Murat Topbas⁴, Erdem Cevik², Ali Osman Yildirim², Ahmet Uzun², Umit Kaldirim²

  (1) Department of Emergency Medicine, Faculty of Medicine,Karadeniz Technical University, Trabzon - Turkey
  (2) Department of Emergency Medicine, Gülhane MilitaryMedical Academy, Ankara - Turkey
  (3) Division of Nephrology, Department of Internal Medicine,Gülhane Military Medical Academy, Ankara - Turkey
  (4) Department of Public Health, Faculty of Medicine, KaradenizTechnical University, Trabzon - Turkey

• Renal ß2-adrenoceptor blockade worsens the outcome of an induced Escherichia coli renal infection
  

  Akio Nakamura¹, Ryo Niimi¹, Yukishige Yanagawa¹

  (1) Department of Pediatrics, Teikyo University School ofMedicine, Tokyo - Japan

• Association between rosiglitazone use and decline in renal function in patients with type 2 diabetes mellitus
  

  Leonid Feldman^1,2, Michal Shani^3,4, Shai Efrati^1,2, Ilia Beberashvili¹, Tuvia Baevsky⁵, Joshua Weissgarten^1,2, Shlomo Vinker^3,4

  (1) Nephrology Division, Assaf Harofeh Medical Center, Zerifin - Israel
  (2) and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv - Israel
  (3) Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv - Israel
  (4) and Family Medicine Department, Clalit Health Services, Central District, Rishon le Zion - Israel
  (5) Family Medicine Department, Clalit Health Services, Central District, Rishon le Zion - Israel

• Rituximab monotherapy for remission induction of proliferative lupus nephritis flares: description of 3 cases
  

  Gabriella Moroni¹, Beniamina Gallelli¹, Giovanni Banfi¹, Antonio Leoni¹, Piergiorgio Messa¹

  (1) Division of Nephrology and Dialysis, IRCCS Fondazione Ospedale Maggiore, Mangiagalli, Regina Elena, Milan - Italy

• Erratum
  []